|
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organizes a number of activities to achieve this aim, such as a yearly congress, schools, workshops, seminars and supported talks. == History == In 1984 representatives of neuropsychopharmacological societies from across Europe suggested there might be room for a European structure. A meeting to discuss this plan further was held in Copenhagen in May 1985. It was decided that a European College of Neuropsychopharmacology would be founded. A Working Group was formed to plan of the association’s inaugural scientific congress. This congress was held in Brussels in 1987. Around 500 people attended. The Working Group consisted of: *Carlos Ballús, Spain *Per Bech, Denmark *Giovanni Cassano, Italy *Alexandra Delini-Stula, Switzerland *Markus Gastpar, Switzerland *Carl-Gerhard Gottfries, Sweden *Lars F. Gram, Denmark *Max Hamilton, United Kingdom *Paul Kielholz, Switzerland *Julien Mendlewicz, Belgium *Giorgio Racagni, Italy *Eckart Ruther, Germany *Michael Trimble, United Kingdom *Willem Verhoeven, Netherlands *Jennifer Wakelin, Netherlands *Édouard Zarifian, France In 1993 the College established a permanent secretariat in Utrecht, Netherlands.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「European College of Neuropsychopharmacology」の詳細全文を読む スポンサード リンク
|